Weight-Loss Drug Also Protects against Heart Disease. What Happens Next?
Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashed risk of heart attacks and other cardiovascular incidents in a trial
Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashed risk of heart attacks and other cardiovascular incidents in a trial
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
